Latest News and Press Releases
Want to stay updated on the latest news?
-
加州卡爾弗城, Nov. 15, 2025 (GLOBE NEWSWIRE) -- 全球領先的互動數碼娛樂獨立開發商和發行商 Snail, Inc. (Nasdaq: SNAL)(「Snail Games」或「公司」) 今天公佈旗下獨立發行部門 Wandering Wizard 發佈了《Rebel Engine》的最新遊戲預告片,其獨特的戰鬥系統成為焦點所在。《Rebel Engine》於...
-
加利福尼亚州卡尔弗城, Nov. 15, 2025 (GLOBE NEWSWIRE) -- 全球领先的互动数字娱乐领域独立开发与发行商 Snail, Inc. (Nasdaq: SNAL,以下简称 “Snail Games” 或“公司”) 今日宣布,其独立游戏发行分支 Wandering Wizard 发布了《反抗引擎》的全新实机演示预告片,重点展示了游戏独具特色的战斗系统。《反抗引擎》在...
-
Houston, TX, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Dynamix Corporation III (the “Company”) today announced that commencing November 19, 2025, holders of the units sold in the Company’s initial public...
-
TORONTO, ONTARIO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”), a life science company focused on natural ingredients and...
-
Beneficient (Nasdaq: BENF) today reported its financial results for the fiscal 2026 second quarter, which ended September 30, 2025.
-
Total Revenue of $77.7 million, an increase of approximately 15% quarter-over-quarterNet Income of $1.3 millionRecord Adjusted EBITDA of $56.3 million, an increase of over 45%...
-
Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy
-
NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that it had sold its...
-
–Fast Track Designation was granted for BB-301 following U.S. Food and Drug Administration (FDA) review of positive interim clinical study results and proprietary Responder Analysis planned for use in...
-
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results